In a separate financing round, Pandorum Technologies announced the close of an $18 million Series B financing to support the ...

Biotech firm Pandorum Technologies announced on Monday the closing of a $18 million in Series B financing round, led by Protons Corporate ...

Indian biotech Pandorum Technologies biotechnology company pioneering programmable regenerative medicine, with operations in India and the USA, has announced the closing of a $18 million in Series B ...

Founded by Tuhin Bhowmick and Arun Chandru, Pandorum’s proprietary platform combines biology, engineering, and computation to ...

The Bengaluru-based company, which operates in India and the United States, said the financing will support the development ...

In today’s Pharmaceutical Executive Daily, frontline biopharma sales professionals are increasingly turning to specialized wealth management advisory services, QuantX Biosciences and Pandorum ...

Pandorum’s primary focus is on ocular surface diseases, such as Stevens–Johnson Syndrome and Neurotrophic Keratitis, for ...

Pandorum Technologies secures $18 million in Series B funding to enhance regenerative therapies and expand global market access.

Pandorum Technologies, a biotech startup, has successfully raised $18 million in a Series B funding round led by Protons Corporate and other investors.

Hopefully you haven't forgotten about Pandorum yet? As a reminder, it's the sci-fi horror thriller from German director Christian Alvart, starring Dennis Quaid and Ben Foster. You should've seen the ...